Komrokji, R. S., Carraway, H. E., Germing, U., Wermke, M., Zeidan, A. M., Fu, E., Rüter, B., Burkard, U., Osswald, A. and Foran, J. M. (2022) “A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome”, Haematologica. Pavia, Italy, 107(11), pp. 2742-2747. doi: 10.3324/haematol.2021.280500.